Report #2853927

Received Aug 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 54 yrs
State: RI
Recovered: Recovered
Vaccinated: Apr 27, 2024
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Herpes zoster

Symptom narrative

she developed shingles; This non-serious case was reported by a consumer and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 27-APR-2024, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: she developed shingles). The outcome of the shingles was resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 04-AUG-2025 The patient reported she received the first shot of Shingrix and a couple months after receiving the vaccine she developed shingles in 2024. The patient reported she never received the second dose of vaccine.